Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Respironics, Inc. (NasdaqNM:RESP)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
Aug 27Price hit new 52-week high ($36.75)
Location
1501 Ardmore Boulevard
Pittsburgh, PA 15221
Phone: (412) 731-2100
Fax: (724) 733-0299
Email: dan.bevevino@respironics.com
Employees (last reported count): 1,900
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 32%
·Over the last 6 months:
 · 10 insider sells; 164.0K shares
  (1.7% of insider shares)
·Institutional: 73% (107% of float)
(309 institutions)
·Net Inst. Selling: 1.23M shares (+5.88%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Respironics, Inc. is a developer, manufacturer and marketer of medical devices used for the treatment of patients suffering from respiratory disorders. The Company's primary product lines are homecare products, including continuous positive airway pressure devices and bi-level positive airway pressure devices used in the home for the treatment of obstructive sleep apnea, respiratory devices including bi-level non-invasive ventilatory support units, portable invasive volume ventilator units used in the home, home oxygen devices, and diagnostic and monitoring systems, hospital products, including bi-level non-invasive ventilatory support units, critical care units that can deliver both non-invasive and invasive ventilation, and portable invasive volume ventilator units, all of which are used in hospital or institutional settings; and asthma and allergy products.
More from Market Guide: Expanded Business Description

Financial Summary
RESP develops, manufactures, and markets medical devices used for the treatment of patients suffering from respiratory disorders. These products are used in homes, hospitals, and in emergency situations. For the fiscal year ended 6/30/01, net sales rose 15% to $422.4 million. Net income totaled $33.6 million, up from $5.8 million. Revenues reflect higher unit sales of obstructive sleep apnea therapy devices. Earnings reflect a $1.2 million restructuring credit vs. a $29.2 million charge.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 115,618; after tax earnings were 9,957. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Gerald McGinnis, 66
Chairman
--  
James Liken, 51
Pres, CEO
$153K
Geoffrey Waters, 50
Pres--International
--  
Craig Reynolds, 51
Exec. VP, COO
359K
Robert Crouch, 52
Sr. VP of New Ventures and Corp. Services
316K
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:RESPAs of 31-Aug-2001
Price and Volume
52-Week Low
on 2-Oct-2000
$15.688
Recent Price$33.51 
52-Week High
on 27-Aug-2001
$36.75 
Beta0.40 
Daily Volume (3-month avg)242.0K
Daily Volume (10-day avg)383.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+77.5%
52-Week Change
relative to S&P500
+138.2%
Share-Related Items
Market Capitalization$1.02B
Shares Outstanding30.3M
Float20.6M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 20-Mar-1995
Per-Share Data
Book Value (mrq*)$6.51 
Earnings (ttm)$1.09 
Earnings (mrq)$0.32 
Sales (ttm)$13.70 
Cash (mrq*)$0.42 
Valuation Ratios
Price/Book (mrq*)5.15 
Price/Earnings (ttm)30.83 
Price/Sales (ttm)2.45 
Income Statements
Sales (ttm)$422.4M
EBITDA (ttm*)$72.9M
Income available to common (ttm)$33.6M
Profitability
Profit Margin (ttm)7.9%
Operating Margin (ttm)11.3%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)9.27%
Return on Equity (ttm)16.39%
Financial Strength
Current Ratio (mrq*)4.17 
Debt/Equity (mrq*)0.43 
Total Cash (mrq)$27.3M
Short Interest
As of 8-Aug-2001
Shares Short196.0K
Percent of Float1.0%
Shares Short
(Prior Month)
159.0K
Short Ratio1.34 
Daily Volume146.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.